From Psychiatry to Neurology: #Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders 1/5 doi.org/10.1111/jnc.15…
The studies of #psychedelics, especially psychedelic tryptamines like #psilocybin, are rapidly gaining interest in neuroscience research. Much of this interest stems from recent clinical studies demonstrating that they have a unique ability t... 2/5
o improve the debilitating symptoms of major depressive disorder (MDD) long-term after only a single treatment. Indeed, the Food and Drug Administration (FDA) has recently designated two Phase III clinical trials studying the ability of psi... 3/5
locybin to treat forms of MDD with "Breakthrough Therapy" status. If successful, the use of #psychedelics to treat psychiatric diseases like depression would be revolutionary. As more evidence appears in the scientific literature to support ... 4/5
Date: September 2021 Authors: Urszula Kozlowska, Charles Nichols, Kalina Wiatr, Maciej Figiel 5/5
• • •
Missing some Tweet in this thread? You can try to
force a refresh
